“Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)”. SKIN The Journal of Cutaneous Medicine 7, no. 4 (July 17, 2023): s220. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2195.